MENIK
The computed 12-month bankruptcy probability of MENIK is 0.2% (very low). The 2024 annual accounts show equity of €1k and a net result of €26k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 6550 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1k |
| Net result | €26k |
| Better than sector | 5% |
| Active | 4 yrs |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 1.0% | 66.7% | |
| Net result | €26k | €46k | |
| Equity | €1k | €79k | |
| Gross operating margin | €46k | €78k | |
| Total assets | €147k | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €46k |
| Net profit | €26k |
| Cash flow | €34k |
| Staff costs | - |
| Income taxes | €10k |
| Dividends | €80k |
| Total assets | €147k |
| Equity | €1k |
| Debt | €146k |
| of which ≤ 1y | €56k |
| of which > 1y | €90k |
| Working capital | €-34k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.39 |
| Quick ratio | 0.39 |
| Working capital ratio | -23.0% |
| Solvency | 1.0% |
| Debt / equity | 102.04 |
| Long-term debt ratio | 63.10 |
| Interest coverage | 18.53 |
| Gross margin | - |
| Net margin | - |
| ROA | 17.8% |
| ROE | 1838.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €147k |
| Fixed assets | 21/28 | €125k |
| Tangible fixed assets | 22/27 | €125k |
| Current assets | 29/58 | €22k |
| Amounts receivable within one year | 40/41 | €137 |
| Cash & bank | 54/58 | €16k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €147k |
| Equity | 10/15 | €1k |
| Contributions / capital | 10/11 | €1k |
| Reserves | 13 | €29 |
| Amounts payable | 17/49 | €146k |
| Amounts payable after one year | 17 | €90k |
| Amounts payable within one year | 42/48 | €56k |
| Income statement | ||
| Gross operating margin | 9900 | €46k |
| Operating result | 9901 | €38k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €36k |
| Income taxes | 67/77 | €10k |
| Net result for the period | 9904 | €26k |
| Result to be appropriated | 9905 | €26k |
| NACE primary | Human health(86951) |
| Legal form | Private limited company(610) |
| Incorporation | 30-09-2021 |
| Status | Active |
| Postal code | 1780 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22005A0183/00E000 | Flanders | 2,602 m² | 1 · 294 m² | 13.0 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
16-10-2023 Registered office moved within Wemmel
- J. Bogemansstraat 108 te 1780 Wemmel → Neerhoflaan 1 bus 0A te 1780 Wemmel
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Neerhoflaan 1 bus 0A te 1780 Wemmel",
"city": "Wemmel",
"region": "vlaams_gewest",
"street": "Neerhoflaan",
"country": "BE",
"postcode": "1780",
"box_number": "0A",
"street_number": null,
"locality_suffix": null
},
"old_address": {
"raw": "J. Bogemansstraat 108 te 1780 Wemmel",
"city": "Wemmel",
"region": "vlaams_gewest",
"street": "J. Bogemansstraat",
"country": "BE",
"postcode": "1780",
"box_number": null,
"street_number": "108",
"locality_suffix": null
},
"effective_date": "2023-09-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-10-16",
"filing_date": "2023-10-06",
"act_kind_objet": "Zetelverplaatsing"
},
"decision": {
"body": "enige_bestuurder",
"date": "2023-07-31",
"unanimous": null
},
"subject_company": {
"kbo": "0774.821.053",
"name_full": "BV Menik",
"legal_form": "BV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0473.332.185",
"org_name": "BV Accountant and Tax Adviser",
"person_name": null,
"org_rep_person_name": "Alain CLUDTS",
"person_role_at_subject": null
},
"co_filed_documents": [
"kopie na neerlegging van de akte ter griffie"
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MENIK |